MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr
Product details
Registration number: SIN07915P
Classification: Prescription Only
Active ingredients: LEVONORGESTREL
Strength: 52 mg
Dosage form: INTRAUTERINE DEVICE
Route: INTRAUTERINE
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
ATC code: G03AC02
HSA approval date: 15 November 1994
Manufacturer(s):
- BAYER OY
- Sterigenics Belgium SA (Petit-Rechain) [Ethylene Oxide Sterlisation]
Manufacturing country/countries: BELGIUM; FINLAND
What are the HSA registration number and classification for MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN07915P
Classification: Prescription Only
What active ingredients and strength are recorded for MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr?
According to the HSA dataset updated 7 August 2026:
Active ingredients: LEVONORGESTREL
Strength: 52 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr?
According to the HSA dataset updated 7 August 2026:
Dosage form: INTRAUTERINE DEVICE
Route: INTRAUTERINE
Who is the recorded registrant for MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr?
According to the HSA dataset updated 7 August 2026:
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
Which manufacturers and countries are listed for MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- BAYER OY
- Sterigenics Belgium SA (Petit-Rechain) [Ethylene Oxide Sterlisation]
Manufacturing country/countries: BELGIUM; FINLAND
Where can I look up MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN07915P or the exact product name MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr. The general register link does not preselect this product.
What are the source dates for this MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MIRENA LEVONORGESTREL INTRAUTERINE SYSTEM 20 mcg/24 hr record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN07915P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)